Dr. John Cush RheumNow
3 years ago
Hong Kong study of 12233 RA pts followed 8.7 yrs, and 7% developed MACE. Daily Pred ≥5 mg signif increased the MACE risk (HR ~ 2), dose-dependent fashion; YET Pred <5 mg/d was not associated with MACE risk (vs No GC) https://t.co/26peaYp4kQ https://t.co/ooax9iTZYo
When we are considering a diagnosis of PMR, it is key to evaluate the patient accurately and efficiently. Can we use a synchronous audiovisual visit or a rheumatology eConsult to evaluate the patient's symptoms quickly? Does it allow us to make an accurate diagnosis? I would argue that for most of these cases we indeed can.
For decades we've been screening GCA with a patient history and exam. Doing so with imaging would be a sharp departure from the current standard of care. And you may be asking yourself, well, yeah, but what could it hurt? Don't you want to catch GCA early?
Let me tell you the problems with this.
Dr. John Cush RheumNow
3 years ago
12.3 million Americans over 50 have osteoporosis; 47 million have osteopenia. W/ OP Fx the risk of repeat Fx is highest in 1st 6 mos, yet 8% of Medicare pts w/ Fx have a diagnostic bone density scan (less in African Americans 5%) https://t.co/xBHr7WffYf https://t.co/S27Vs8yyjY https://t.co/eWcOB8fjWH
Dr. John Cush RheumNow
3 years ago
Sleep problems in SpA & PsA? Study of 201 pts shows 43% of axSpA and 47% of PsA pts reported sleep problems. In both poor sleep assoc w/ dz activity. In axSpa it signif assoc w/ Dz activity (OR 8.45),biologic use (OR .24), & CRP levels (OR .16) https://t.co/7juI2Dghjh https://t.co/SxCaJgTmeQ
Dr. John Cush RheumNow
3 years ago
Bimekizumab (Bimelex), a dual IL-17A/F inhibitor, is FDA approved for u Treatment of Adults with Moderate to Severe Plaque Psoriasis https://t.co/Eo4LMaTHxn https://t.co/abzlThasEN
Dr. John Cush RheumNow
3 years ago
#PMR with Cancer
Dr. Sebastian Sattui (Pittsburgh, PA) Can PMR be a paraneoplastic presentation?
https://t.co/GsQ5FoDGPK https://t.co/ybHMmi72TG
Dr. John Cush RheumNow
3 years ago
Innovative, full-read, state-of-the-art article on IMAGING in INFLAMMATORY ARTHRITIS & its future role in precision medicine. "Imaging is poised to become an invaluable tool in precision medicine..". HR-pQCT, 3T or 7T MRI, FAPI PET–CT, CEUS, FOI, etc https://t.co/fGQVEOkea9 https://t.co/XyvtZj85Hk
Dr. John Cush RheumNow
3 years ago
Check out my other podcast - the Miracle Larry Podcast. Miracle Larry gave the keynote lecture at RNL2023. A podcast focused on his amazing story. Follow us @Miracle_LarryK. We’d appreciate the support!
https://t.co/6zi2D7hdGJ
Dr. John Cush RheumNow
3 years ago
What Goes Wrong with the Immune System in #PMR?
https://t.co/3DDFXBOfaL https://t.co/WNiWpokP4q
Dr. John Cush RheumNow
3 years ago
Using Methotrexate in #PMR
Where in other inflammatory rheumatic disorders, such as RA and PsA, early initiation of MTX is common practice, this is not the case in PMR. Treatment of PMR is still largely based on GC.
https://t.co/pQtmYvF2NS https://t.co/wJTpFPqmlw
Dr. John Cush RheumNow
3 years ago
#PMR and Palindromic Rheumatism Similarities
https://t.co/uJ4hJSA0hL https://t.co/rFINkKZh7l
Dr. John Cush RheumNow
3 years ago
Check out the latest therapeutic update for axSpA in this video series dedicated to creating a better understanding of treatment goals.https://t.co/VTQI0SzHpO https://t.co/H3yBcnUvwu
Dr. John Cush RheumNow
3 years ago
2023 EULAR Lupus Management Recommendations
EULAR has published updated recommendations for the management of systemic lupus erythematosus (SLE) based on new evidence and expert opinion - formulationg five overarching principles and 13 recommendations.
https://t.co/Fzh8F33u3U https://t.co/2baAVsm8Bo

